s6y
Company name or ticker
Search
RELMADA THERAPEUTICS, INC.
8-K
Current report filing
Filed
Thursday, June 8, 2017
Period
Jun 6, 2017
Accession number
0001213900-17-006258
Documents
CURRENT REPORT
8-K
On sec.gov
Filing index
All files
Complete submission text
SGML header